Locations:
Search
While statins reduce cardiovascular diseases, only about one-half of eligible patients receive treatment
Adding PCSK9 inhibitor to statins dropped cholesterol levels to lowest ever studied in a major clinical trial
Clinical Trial Stopped Early After Preliminary Data Indicated Drug Was Not Effective